Marksans Pharma’s subsidiary -- Time-Cap Laboratories Inc has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its manufacturing facility located at Michael Avenue, Farmingdale, New York, USA. Current Good Manufacturing Practices (cGMP) inspection was conducted by the USFDA from April 16, 2025 to April 24, 2025.
Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.